QR-Code

Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients

Mucous membrane pemphigoids (MMPs) and bullous pemphigoid (BP) are autoimmune bullous diseases that share physiopathological features: both can result from autoantibodies directed against BP180 or BP230 antigens. An association has been reported between BP and intake of gliptins, which are dipeptidy...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Olivier Gaudin, Vannina Seta, Marina Alexandre, Gérôme Bohelay, Françoise Aucouturier, Sabine Mignot-Grootenboer, Saskia Ingen-Housz-Oro, Céline Bernardeschi, Pierre Schneider, Benoît Mellottee, Frédéric Caux, Catherine Prost-Squarcioni
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2018-05-01
Schriftenreihe:Frontiers in Immunology
Schlagworte:
autoimmune bullous diseases
mucous membrane pemphigoid
fibrosis
dipeptidyl peptidase IV inhibitor
gliptin
diabetes mellitus
Online-Zugang:https://www.frontiersin.org/article/10.3389/fimmu.2018.01030/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge